Physiomics Plc

Physiomics PLC is a UK-based oncology contract research organisation (CRO) that provides services to pharmaceutical and biotech companies. Its primary aim is to help accelerate the development of new cancer treatments through advanced modelling and simulation. The company supports drug discovery and development globally. Operating within the life sciences sector, Physiomics PLC specialises in predictive oncology. It utilises proprietary computer models and simulations to forecast the efficacy and toxicity of potential cancer drugs. This aims to optimise clinical trial design and de-risk drug development. Monitor the PYC.L share price by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.